Therapeutic monitoring of vanco- mycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists [published correction appears in Am J Health Syst Pharm. 2009;66:887]. Am J Health Syst Pharm. 2009;66:82 98. doi: 10.2146/ajhp080434. 113. Kullar R, Davis SL, Levine DP, Rybak MJ. Impact of vancomycin expo- sure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis. 2011;52:975 981. doi: 10.1093/cid/cir124. 114. Bai AD, Showler A, Burry L, Steinberg M, Ricciuto DR, Fernandes T, Chiu A, Raybardhan S, Science M, Fernando E, Tomlinson G, Bell CM, Morris AM. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacte- remia: results from a large multicenter cohort study. Clin Infect Dis. 2015;60:1451 1461. doi: 10.1093/cid/civ120. 115. Yamamoto S, Hosokawa N, Sogi M, Inakaku M, Imoto K, Ohji G, Doi A, Iwabuchi S, Iwata K. Impact of infectious diseases service consultation on diagnosis of infective endocarditis. Scand J Infect Dis. 2012;44:270 275. doi: 10.3109/00365548.2011.638317. 116. Morris AJ, Drinkovi D, Pottumarthy S, MacCulloch D, Kerr AR, West T. Bacteriological outcome after valve surgery for active infective endo- carditis: implications for duration of treatment after surgery. Clin Infect Dis. 2005;41:187 194. doi: 10.1086/430908. 117. Mu oz P, Giannella M, Scoti F, Predomingo M, Puga D, Pinto A, Roda J, Marin M, Bouza E; Group for the Management of Infective Endocarditis of the Gregorio Mara n Hospital (GAME). Two weeks of postsurgi- cal therapy may be enough for high-risk cases of endocarditis caused by Streptococcus viridans or Streptococcus bovis. Clin Microbiol Infect. 2012;18:293 299. doi: 10.1111/j.1469-0691.2011.03594.x. 118. Francioli P, Etienne J, Hoign R, Thys JP, GerberA. 